Physician profile
Michael J Lyons
NPI 1407847296
$501.31
in general payments reported to CMS, 2019-2025
9 companies · $27.00 in 2025
The $27.00 reported for 2025 was less than what a typical Clinical Genetics (M.D.) provider received nationally (typical 2025 total: $255).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.24 · 2020: $46.58 · 2021: $39.23 · 2022: $55.93 · 2023: $128 · 2024: $165 · 2025: $27.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Illumina, INC. | $122.99 | 2024 | Genetic Disease Testing |
| Novartis Pharmaceuticals Corporation | $93.62 | 2021-2023 | |
| Genzyme Corporation | $87.19 | 2019-2022 | |
| Ultragenyx Pharmaceutical INC. | $72.39 | 2022-2023 | Dojolvi |
| Sarepta Therapeutics, INC. | $41.51 | 2024 | |
| Stryker Corporation | $27.00 | 2025 | Anchorage |
| Rhythm Pharmaceuticals, INC. | $26.04 | 2022 | |
| Travere Therapeutics, INC. | $18.74 | 2019-2021 | |
| Biogen, INC. | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.